Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 144: | Line 144: | ||
*[[Disseminated intravascular coagulation|DIC]] | *[[Disseminated intravascular coagulation|DIC]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Myelofibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Myelofibrosis]]<ref name="BaePark2013">{{cite journal|last1=Bae|first1=E.|last2=Park|first2=C.-J.|last3=Cho|first3=Y.-U.|last4=Seo|first4=E.-J.|last5=Chi|first5=H.-S.|last6=Jang|first6=S.|last7=Lee|first7=K.-H.|last8=Lee|first8=J.-H.|last9=Lee|first9=J.-H.|last10=Suh|first10=J.-J.|last11=Im|first11=H.-J.|title=Differential diagnosis of myelofibrosis based on WHO 2008 criteria: Acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis|journal=International Journal of Laboratory Hematology|volume=35|issue=6|year=2013|pages=629–636|issn=17515521|doi=10.1111/ijlh.12101}}</ref> | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Bone marrow infiltration | * Bone marrow infiltration | ||
Line 152: | Line 152: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |Average 60 years old | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[Pallor]] | * [[Pallor]] | ||
* Major weight loss | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |- | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*[[Muscle weakness|Weakness]] | |||
*[[Fatigue]] | |||
* [[Dyspnea|Shortness of breath]] | |||
* [[Headache]] | |||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*[[Pancytopenia]] | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[Pancytopenia]] | |||
*Hypercellular [[bone marrow]] | |||
*[[Fibrosis]] | |||
| align="center" style="background:#F5F5F5;" + |↑ | |||
| align="center" style="background:#F5F5F5;" + |↑ | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*[[Hemoglobinuria]] | |||
| align="center" style="background:#F5F5F5;" + |NA | |||
| align="center" style="background:#F5F5F5;" + |Bone marrow examination | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| | * [[Cardiac arrhythmia|Arrhythmia]] | ||
* [[Infection]] | |||
* [[Seizure]] | |||
* May progress to malignancy | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Fanconi anemia | ! align="center" style="background:#DCDCDC;" |Fanconi anemia |
Revision as of 18:59, 10 September 2018
Differentiating Pancytopenia from Other Diseases
- There are no other mimickers of pancytopenia, as the diagnosis can be unequivocally established by laboratory testing (complete blood count).
Category | Condition | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | ||||||||||||||||||||||||
Lab Findings | Imaging | ||||||||||||||||||||||||||
Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | |||||||||||||||
Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Plt | HB | WBC | ||||||||||||||||||||||
Hematologic disorders | Myelodysplastic syndrome |
|
+ | + | - | ± | + | Elderly | Exposure to | + | + | Nl | + | + | ↓ | ↓ | ↓ |
|
|
Nl | Nl | Nl | NA | Bone marrow examination + clinical manifestation |
| ||
Malignancies such as: |
|
+ | + | + | ± | ± | Any, more in adults |
|
+ | + | Nl | + | - | ↓ | ↓ | ↓ |
|
↑ | ↑ | NA | Bone marrow examination |
| |||||
Myelofibrosis[1] |
|
+ | + | - | + | + | Average 60 years old |
|
+ | + | Nl | + | - | ↓ | ↓ | ↓ |
|
↑ | ↑ | NA | Bone marrow examination |
| |||||
Fanconi anemia | |||||||||||||||||||||||||||
Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Aplastic anemia |
|
+ | |||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | Immune destruction | + | |||||||||||||||||||||||||
Disseminated intravascular coagulation | Consumption | ||||||||||||||||||||||||||
Dyskeratosis congenital/telomere biology disorders | |||||||||||||||||||||||||||
Shwachman-Diamond syndrome | + | ||||||||||||||||||||||||||
Immunology/
Rheumatology |
Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |
SLE | |||||||||||||||||||||||||||
Felty syndrome | |||||||||||||||||||||||||||
Wiskott Aldrich syndrome | + | ||||||||||||||||||||||||||
GATA2 deficiency | + | ||||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis (HLH) | + | ||||||||||||||||||||||||||
GI disorders | Portal hypertension/cirrhosis |
|
|||||||||||||||||||||||||
Storage diseases (eg, Gaucher) |
|
+ | + | ||||||||||||||||||||||||
Infections | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |
Sepsis |
|
||||||||||||||||||||||||||
Viral infection such as HIV, hepatitis, Epstein-Barr virus |
|
+ | + | ||||||||||||||||||||||||
Nutritional | Megaloblastic anemia |
|
+ | ||||||||||||||||||||||||
Excessive alcohol |
|
||||||||||||||||||||||||||
Other (eg, copper deficiency, zinc toxicity) |
|
||||||||||||||||||||||||||
Malnutrition |
|
||||||||||||||||||||||||||
Medications | Medications such as:
|
|
+ | ||||||||||||||||||||||||
Category | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |
- ↑ Bae, E.; Park, C.-J.; Cho, Y.-U.; Seo, E.-J.; Chi, H.-S.; Jang, S.; Lee, K.-H.; Lee, J.-H.; Lee, J.-H.; Suh, J.-J.; Im, H.-J. (2013). "Differential diagnosis of myelofibrosis based on WHO 2008 criteria: Acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis". International Journal of Laboratory Hematology. 35 (6): 629–636. doi:10.1111/ijlh.12101. ISSN 1751-5521.